KAPA$0.50+5.60%
Kairos Pharma, LTD.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: NYSE
Mkt Cap:$1.69M
Float & O/S:
Inst Own:
DilutionScan read 26 of Kairos Pharma, LTD.'s SEC filings and found 7 warrant series, 1 ATM program, 1 equity line, 1 shelf registration, 2 S-1 registrations and 2 completed offerings on file for KAPA. The latest dilution event on file is ATM sales on Aug 12, 2026. Analysis updated Nov 3, 2026.